Metraipolis › archive › dc_e2dcccce2e03
Efficacy and influencing factors analysis of SGLT2 inhibitors in treating heart failure following acute myocardial infarction — Europe PMC PMID:41244824
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41244824
- DOI
- 10.3389/fphar.2025.1693420
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T22:32:15.465Z
- SHA-256 of the archived text
1db689c8286ea97776fee9d166db457a2b2a8b73496961c36fcc232d0fc5c0c5- Stable URL of this page
https://metraipolis.com/documento/dc_e2dcccce2e03
How to cite
Efficacy and influencing factors analysis of SGLT2 inhibitors in treating heart failure following acute myocardial infarction — Europe PMC PMID:41244824 — Europe PMC (en), https://europepmc.org/article/MED/41244824 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2dcccce2e03 (Metraipolis archive dc_e2dcccce2e03, sha256 1db689c8286ea97776fee9d166db457a2b2a8b73496961c36fcc232d0fc5c0c5)
BibTeX
@misc{dce2dcccce2e03,
title = {Efficacy and influencing factors analysis of SGLT2 inhibitors in treating heart failure following acute myocardial infarction — Europe PMC PMID:41244824},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41244824},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2dcccce2e03; sha256 1db689c8286ea97776fee9d166db457a2b2a8b73496961c36fcc232d0fc5c0c5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41244824. Agents can read the archived copy with the MCP tool read_document.